Producers of Engineered Nanomaterials-What Motivates Company and Worker Participation in Biomonitoring Programs?

engineered nanomaterials exposure assessment human biomonitoring programs occupational exposure online survey participation propensity

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
07 04 2021
Historique:
received: 22 02 2021
revised: 02 04 2021
accepted: 03 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 25 5 2021
Statut: epublish

Résumé

Production and handling of engineered nanomaterials (ENMs) can yield worker exposure to these materials with the potential for unforeseen negative health effects. Biomonitoring enables regular exposure and health assessment and an effective risk management. We aimed to identify factors influencing biomonitoring acceptance according to hierarchical positions of ENM producers. Managers and workers were invited to complete an online questionnaire. Forty-three companies producing or handling ENMs such as titanium dioxide (61%) and multi-walled carbon nanotubes (44%) participated. The majority of managers (72%) and all workers responded positively to participating in biomonitoring studies. The main reasons for refusing participation included concerns about data confidentiality and sufficient knowledge about ENM health and safety. Acquisitions of individual study results, improvement of workers' safety, and help to the development of ENM-specific health and safety practice were among the most valuable reasons for positively considering participation. All workers indicated feeling comfortable with biomonitoring procedures of exhaled air sampling-about half were similarly comfortable with exhaled breath condensate, urine, and buccal cell sampling. The majority of both workers and managers stated that participation in a biomonitoring program should take place during working hours. Although our survey only had limited participation, our results are useful in designing appropriate biomonitoring programs for workers exposed to ENMs.

Identifiants

pubmed: 33916897
pii: ijerph18083851
doi: 10.3390/ijerph18083851
pmc: PMC8067629
pii:
doi:

Substances chimiques

Nanotubes, Carbon 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Hyg Environ Health. 2019 Jun;222(5):727-737
pubmed: 31176761
Ann Occup Hyg. 2016 Oct;60(8):916-35
pubmed: 27422281
Ann Work Expo Health. 2017 Jan 1;61(1):87-97
pubmed: 28395313
Int J Hyg Environ Health. 2017 Oct;220(7):1089-1097
pubmed: 28711303
Nanotoxicology. 2016 Sep;10(7):1013-9
pubmed: 26865347
Scand J Work Environ Health. 2019 May 1;45(3):217-238
pubmed: 30653633
J Epidemiol Community Health. 2018 Feb;72(2):148-153
pubmed: 29203525
J Bioeth Inq. 2015 Jun;12(2):227-37
pubmed: 25672617
Hum Exp Toxicol. 2008 Jan;27(1):5-21
pubmed: 18480145
PLoS One. 2016 Nov 9;11(11):e0166071
pubmed: 27829014
Can J Public Health. 2010 Mar-Apr;101(2):159-64
pubmed: 20524383
Epidemiology. 2016 Sep;27(5):765-8
pubmed: 27054652
J Occup Environ Hyg. 2010 Apr;7(4):224-32
pubmed: 20155559
AIHA J (Fairfax, Va). 2002 Mar-Apr;63(2):205-12
pubmed: 11975658
Int J Environ Res Public Health. 2019 Sep 07;16(18):
pubmed: 31500229
Regul Toxicol Pharmacol. 2011 Feb;59(1):125-32
pubmed: 20933039
Environ Int. 2018 Jul;116:214-228
pubmed: 29698898
Int J Hyg Environ Health. 2016 Mar;219(2):166-75
pubmed: 26752069
Toxicol Lett. 2018 Dec 1;298:112-124
pubmed: 29920308

Auteurs

Camille Crézé (C)

Department of Occupational and Environmental Health, Center for Primary Care and Public Health (Unisanté), University of Lausanne, 1066 Epalinges, Lausanne, Switzerland.

Marjorie François (M)

Department of Occupational and Environmental Health, Center for Primary Care and Public Health (Unisanté), University of Lausanne, 1066 Epalinges, Lausanne, Switzerland.

Nancy B Hopf (NB)

Department of Occupational and Environmental Health, Center for Primary Care and Public Health (Unisanté), University of Lausanne, 1066 Epalinges, Lausanne, Switzerland.

Victor Dorribo (V)

Department of Occupational and Environmental Health, Center for Primary Care and Public Health (Unisanté), University of Lausanne, 1066 Epalinges, Lausanne, Switzerland.

Jean-Jacques Sauvain (JJ)

Department of Occupational and Environmental Health, Center for Primary Care and Public Health (Unisanté), University of Lausanne, 1066 Epalinges, Lausanne, Switzerland.

Enrico Bergamaschi (E)

Laboratory of Toxicology and Industrial Epidemiology, Department of Public Health and Pediatrics, University of Torino, 10126 Torino, Italy.

Giacomo Garzaro (G)

Laboratory of Toxicology and Industrial Epidemiology, Department of Public Health and Pediatrics, University of Torino, 10126 Torino, Italy.

Maida Domat (M)

Instituto Tecnológico del Embalaje, Transporte y Logística (ITENE), 46980 Paterna, Valencia, Spain.

Judith Friesl (J)

Yordas GmbH, 91301 Forchheim, Germany.

Eva Penssler (E)

Yordas GmbH, 91301 Forchheim, Germany.

Athena Progiou (A)

ALCON Consultant Engineers Ltd., 11257 Athens, Greece.

Irina Guseva Canu (I)

Department of Occupational and Environmental Health, Center for Primary Care and Public Health (Unisanté), University of Lausanne, 1066 Epalinges, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH